0001567619-19-018774.txt : 20190926
0001567619-19-018774.hdr.sgml : 20190926
20190926105130
ACCESSION NUMBER: 0001567619-19-018774
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190925
FILED AS OF DATE: 20190926
DATE AS OF CHANGE: 20190926
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jackson Steven D.
CENTRAL INDEX KEY: 0001654405
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35929
FILM NUMBER: 191116093
MAIL ADDRESS:
STREET 1: C/O NATIONAL RESEARCH CORPORATION
STREET 2: 1245 Q STREET
CITY: LINCOLN
STATE: NE
ZIP: 68508
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NATIONAL RESEARCH CORP
CENTRAL INDEX KEY: 0000070487
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 470634000
STATE OF INCORPORATION: WI
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1245 Q STREET
CITY: LINCOLN
STATE: NE
ZIP: 68508
BUSINESS PHONE: 4024752525
MAIL ADDRESS:
STREET 1: 1245 Q STREET
CITY: LINCOLN
STATE: NE
ZIP: 68508
4
1
doc1.xml
FORM 4
X0306
4
2019-09-25
0
0000070487
NATIONAL RESEARCH CORP
NRC
0001654405
Jackson Steven D.
C/O NATIONAL RESEARCH CORPORATION
1245 Q STREET
LINCOLN
NE
68508
0
1
0
0
President
Common Stock
2019-09-25
4
S
0
4000
60.7889
D
93596
D
Employee Stock Option (Right to Buy)
15.23
2026-01-05
Common Stock
21535
21535
D
Employee Stock Option (Right to Buy)
18.80
2027-01-04
Common Stock
17608
17608
D
Employee Stock Option (Right to Buy)
36.80
2028-01-03
Common Stock
12228
12228
D
Employee Stock Option (Right to Buy)
38.30
2029-01-03
Common Stock
11749
11749
D
The price in Column 4 is a weighted average price. The prices actually received ranged from $60.75 to $60.8945. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
This option becomes fully exercisable on January 5, 2021.
This option becomes fully exercisable on January 4, 2022.
This option becomes fully exercisable on January 3, 2023.
This option becomes fully exercisable on January 3, 2024.
/s/ Russell E. Ryba, Attorney-in-Fact for Steven D. Jackson
2019-09-26